News

Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...
Valued at a market cap of $28 billion, Humana Inc. (HUM) is a leading U.S. health care plan provider offering medical and specialty insurance products. Operating through its Insurance and CenterWell ...
Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...
Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...
It’s a significant loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.
Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.
What Analysts Are Saying About Humana Stock May 01, 2025 — 06:01 pm EDT. ... Humana showcased positive performance, achieving a revenue growth rate of 10.4% as of 31 December, 2024.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
This stock's P/B looks attractive against its industry's average P/B of 2.20. Within the past 52 weeks, HUM's P/B has been as high as 2.91 and as low as 1.52, with a median of 1.93. Value ...
This was the stock's second consecutive day of losses.
This was the stock's fourth consecutive day of losses.